Piergiorgio Pettazzoni

5PUBLICATIONS
41CO-AUTHORS
Molecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 04, 2025
Mosperafenib, a Novel Paradox-Breaker BRAF Inhibitor with Potent Preclinical Activity in BRAF-Mutated Colorectal Cancer.

Florian Renner, Jan Eckmann, Cornelia Handl

|Dec 21, 2022
WRN helicase and mismatch repair complexes independently and synergistically disrupt cruciform DNA structures.

Valentina Mengoli, Ilaria Ceppi, Aurore Sanchez

|May 18, 2022
Activity and Resistance of a Brain-Permeable Paradox Breaker BRAF Inhibitor in Melanoma Brain Metastasis.

Ester Bonfill-Teixidor, Raffaella Iurlaro, Cornelia Handl

|May 17, 2022
DUSP4 protects BRAF- and NRAS-mutant melanoma from oncogene overdose through modulation of MITF.

Nuria Gutierrez-Prat, Hedwig L Zuberer, Luca Mangano

Pageof 1